Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
Low-leveraged balance sheets, sizeable liquidity to keep credit profiles stable
The products will be manufactured at the company's facility in Bengaluru
The Leaders of G20 met in New Delhi and committed to strengthening global health and implementing one health approach
Zilebesiran demonstrated an encouraging safety and tolerability profile in adult patients with mild-to-moderate hypertension
The company will develop and produce premixes for human nutrition applications
The state-of-the-art digital PETCT imaging system, highlights a significant advancement in the fight against cancer and detects other lesions offering patient centric services
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
This collaboration marks a significant milestone in countering the disease burden by enhancing access to products for patients in the US
Subscribe To Our Newsletter & Stay Updated